ICU MEDICAL INC/DE

For the period ended Jun 30, 2026. Filed Aug 6, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 6, 2026

ICUI$182.11+1.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets at and

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except par value data and treasury shares)

June 30,2026 · December 31,2025
	(Unaudited)	(1)
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$298,299		$307,963
Accounts receivable, net of allowance of $14,292 at June 30, 2026 and $14,383 at December 31, 2025	183,531		180,515
Inventories	607,421		615,859
Prepaid expenses and other current assets	121,657		86,217
TOTAL CURRENT ASSETS	1,210,908		1,190,554
PROPERTY, PLANT AND EQUIPMENT, net	446,798		451,817
OPERATING LEASE RIGHT-OF-USE ASSETS	38,610		54,470
GOODWILL	1,484,384		1,499,754
INTANGIBLE ASSETS, net	567,665		633,559
DEFERRED INCOME TAXES	25,569		25,891
OTHER ASSETS	63,435		62,877
INVESTMENTS IN UNCONSOLIDATED AFFILIATES	133,913		131,586
TOTAL ASSETS	$3,971,282		$4,050,508
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable	$149,165		$154,374
Accrued liabilities	322,489		315,337
Current portion of long-term debt	18,750		18,750
Income tax payable	7,960		10,400
TOTAL CURRENT LIABILITIES	498,364		498,861
LONG-TERM DEBT	1,212,449		1,265,917
OTHER LONG-TERM LIABILITIES	70,994		89,536
DEFERRED INCOME TAXES	12,227		37,756
INCOME TAX LIABILITY	25,397		34,613
COMMITMENTS AND CONTINGENCIES (Note 20)
STOCKHOLDERS’ EQUITY:
Convertible preferred stock, $1.00 par value; Authorized — 500 shares; Issued and outstanding — none	—		—
Common stock, $0.10 par value; Authorized — 80,000 shares; Issued — 25,186 shares at June 30, 2026 and 24,688 shares at December 31, 2025; and outstanding — 25,007 shares at June 30, 2026 and 24,688 shares at December 31, 2025	2,519		2,469
Additional paid-in capital	1,475,974		1,465,118
Treasury stock, at cost (179,637 shares at June 30, 2026 and 172 shares at December 31, 2025)	(23,415)		(22)
Retained earnings	740,109		690,890
Accumulated other comprehensive loss	(43,336)		(34,630)
TOTAL STOCKHOLDERS' EQUITY	2,151,851		2,123,825
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$3,971,282		$4,050,508

(1)December 31, 2025 balances were derived from audited consolidated financial statements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.